BBSRC Portfolio Analyser
Award details
Contained trial of modified capripox-rinderpest vaccine in Kenya
Reference
BBS/E/I/00000619
Principal Investigator / Supervisor
Professor Thomas Barrett
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
19,401
Status
Completed
Type
Institute Project
Start date
01/04/1997
End date
31/03/1999
Duration
24 months
Abstract
A bi-valent recombinant vaccine, for use in cattle and small ruminants against rinderpest/peste des petits ruminants and lumpy skin disease/sheep and goat pox, is based on the expression of the H and F genes of rinderpest virus in a sheep pox virus vector. Initial trials in containment at Pirbright indicated that the recombinant vaccine is effective in protecting UK sourced animals over intervals of a month or so. This project aims to assess the long term (up to 3 years) efficacy and safety of the vaccine in African animals.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search